2-(tert-Butyl) 3-ethyl (3S)-2-azabicyclo[2.2.1]heptane-2,3-dicarboxylate, 95%, 250mg

1-Bromo-2,4-bis(trifluoromethyl)benzene>97.0%(GC)1g

4'-Thiomethyl-2,2,2-trifluoroacetophenone, 97.0%, 1g

(3-(1-Methoxyethyl)phenyl)boronic acid, 95.0%, 1g

Colonne capillaire GC ROTI®Cap-1701 MS, 30 m, 0,25 mm, 0,50 µm, 1 pièce(s)

2-(3-Chloro-4-(cyclopropylmethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

(S)-N-Boc-2-aminomethylmorpholine hydrochloride, 97%, 10g

2-Hydroxyethanethioamide, 95%, 1g

2-(5-Bromothien-2-yl)pyridine, 95.0%, 25g

tert-Butyl 4-((5-bromopyridin-2-yl)oxy)piperidine-1-carboxylate, 98%, 5g

3-Chloro-5-fluoro-2-methylbenzoic acid, 95.0%, 25g

N-Cyclopropyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 96%, 250mg

Acétate d'éthyle, min 99,5 %, pour la synthèse, 25 l, fer blanc.